Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

(OP:QTZM)

0.0500 UNCHANGED
Streaming Delayed Price Updated: 1:49 PM EDT, May 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.0500
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0500
Today's Range 0.0500 - 0.0500
52wk Range 0.0116 - 1.910
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Quantumzyme Responds to OTC Markets Caveat Emptor Designation and Denounces Unauthorized Promotion Activity
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Quantumzyme Responds to OTC Markets Caveat Emptor Designation and Denounces Unauthorized Promotion Activity
SAN DIEGO, CA - April 30, 2025 (NEWMEDIAWIRE) - Quantumzyme Corp. (OTC: QTZM), a biotechnology company leveraging computational enzyme engineering, today announced that it is in contact with OTC... 
Via TheNewswire.com

Performance

YTD
-89.4%
-89.4%
1 Month
-97.2%
-97.2%
3 Month
-89.4%
-89.4%
6 Month
-89.4%
-89.4%
1 Year
-89.4%
-89.4%

More News

Read More
Quantumzyme Highlights Benefits and Commercialization Opportunities of Pending Breakthrough Green Chemistry Patent
Via NewMediaWire
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
Quantumzyme Highlights Benefits and Commercialization Opportunities of Pending Breakthrough Green Chemistry Patent
Via TheNewswire.com
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
Quantumzyme Anticipates Publication of Transformative Patent for Enzymatic Ibuprofen Manufacturing
Via NewMediaWire
Topics Intellectual Property
Exposures Intellectual Property
Quantumzyme Anticipates Publication of Transformative Patent for Enzymatic Ibuprofen Manufacturing
Via TheNewswire.com
Topics Intellectual Property
Exposures Intellectual Property
Quantumzyme Highlights Enzyme Engineering Platform and Ongoing Work in Sustainable Ibuprofen Synthesis
Via NewMediaWire
Quantumzyme: Advancing Enzymatic Innovation for a Sustainable Industrial Future
Via NewMediaWire
Topics Artificial Intelligence
Exposures Artificial Intelligence
Quantumzyme Introduces Manu Bharath Khareedhi as Independent Director, Looks to Strengthen Strategic Growth and Innovation
Via NewMediaWire
Quantumzyme Introduces Manu Bharath Khareedhi as Independent Director, Looks to Strengthen Strategic Growth and Innovation
Via TheNewswire.com
Quantumzyme Signs MOU With Zummit Africa to Establish a Centre of Excellence in AI for Green Chemistry
Via TheNewswire.com
Topics Artificial Intelligence
Exposures Artificial Intelligence
Quantumzyme Signs MOU With Zummit Africa to Establish a Centre of Excellence in AI for Green Chemistry
Via NewMediaWire
Topics Artificial Intelligence
Exposures Artificial Intelligence
Quantumzyme to Become Fully Reporting SEC Issuer, Unlocking New Growth Potential
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
Quantumzyme to Become Fully Reporting SEC Issuer, Unlocking New Growth Potential
Via TheNewswire.com
Topics Regulatory Compliance
Exposures Legal Regulatory
Quantumzyme Highlights Breakthroughs in Enzymatic Catalysis at CCE 2025
Via TheNewswire.com
Topics Emissions
Quantumzyme Highlights Breakthroughs in Enzymatic Catalysis at CCE 2025
Via NewMediaWire
Topics Emissions
Quantumzyme Announces Vision to Lead the Future of Sustainable Industrial Biocatalysis
Via NewMediaWire
Topics Artificial Intelligence
Exposures Artificial Intelligence
Quantumzyme Announces Vision to Lead the Future of Sustainable Industrial Biocatalysis
Via TheNewswire.com
Topics Artificial Intelligence
Exposures Artificial Intelligence
Quantumzyme Unveils Enhanced Website to Drive Innovation and User Engagement
Via TheNewswire.com
Quantumzyme Unveils Enhanced Website to Drive Innovation and User Engagement
Via NewMediaWire

Frequently Asked Questions

Is QTZM publicly traded?
Yes, QTZM is publicly traded.
What exchange does QTZM trade on?
QTZM trades on the OTC Traded
What is the ticker symbol for QTZM?
The ticker symbol for QTZM is QTZM on the OTC Traded
What is the current price of QTZM?
The current price of QTZM is 0.0500
When was QTZM last traded?
The last trade of QTZM was at 05/12/25 01:49 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.